Tower Research Capital (TRC)’s Tobira Therapeutics, Inc. Common Stock TBRA Stock Holding History

Tower Research Capital (TRC)’s Portfolio TBRA Stock Details TBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-50	Closed	-$2K	–	4931
2016 Q3	$2K	Buy	+50	New	+$558	﹤0.01%	3226
2016 Q2	–	Sell	-1,019	Closed	-$8K	–	5424
2016 Q1	$8K	Sell	1,019 -156	-13%	-$1.18K	﹤0.01%	2304
2015 Q4	$12K	Buy	1,175 +253	+27%	+$2.63K	﹤0.01%	1959
2015 Q3	$9K	Buy	922 +148	+19%	+$2.08K	﹤0.01%	2429
2015 Q2	$13K	Buy	+774	New	+$11.3K	﹤0.01%	2500
2014 Q4	–	Sell	-4,636	Closed	-$47K	–	5220
2014 Q3	$47K	Buy	4,636 +3,216	+226%	+$63.5K	0.01%	1588
2014 Q2	$87K	Buy	1,420 +1,392	+4,971%	+$84.7K	0.01%	981
2014 Q1	$3K	Sell	28 -374	-93%	-$26.3K	﹤0.01%	3749
2013 Q4	$17K	Buy	402 +251	+166%	+$11.8K	﹤0.01%	2532
2013 Q3	$9K	Buy	+151	New	+$7.91K	﹤0.01%	3312

Tower Research Capital (TRC)'s TBRA Position: Q4 2016 in Review

Tower Research Capital (TRC) sold out of Tobira Therapeutics, Inc. Common Stock (TBRA) in Q4 2016, closing a stake of 50 shares — an estimated $2K sold.

Tower Research Capital (TRC) first reported a position in TBRA in Q3 2013 and held it in 10 quarters. The position peaked at $87K in Q2 2014. 0 funds tracked by Wall St. Rank hold TBRA as of Q4 2016.

Tower Research Capital (TRC) reported no remaining Tobira Therapeutics, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
Tower Research Capital (TRC) sold 50 Tobira Therapeutics, Inc. Common Stock shares in Q4 2016, an estimated $2K.
Tower Research Capital (TRC) first reported a position in Tobira Therapeutics, Inc. Common Stock in Q3 2013 and held it in 10 quarters.
Tower Research Capital (TRC)'s Tobira Therapeutics, Inc. Common Stock position peaked at $87K in Q2 2014.
0 funds tracked by Wall St. Rank held Tobira Therapeutics, Inc. Common Stock as of Q4 2016.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2016, filed 3 Feb 2017.